Progenics Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
August 08, 2018 at 06:22 AM EDT
Progenics Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 9,090,909 primary shares of its common stock at a public offering price of $8.25 per share.
